Ceapro Inc【CZO】株式ニュース

	リアルタイム株価	レベル2
Forex

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

Aeterna Zentaris and Ceapro Complete Merger Transaction

TORONTO and EDMONTON, Alberta, June 03, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX:...

Aeterna Zentaris and Ceapro Complete Merger Transaction

TORONTO and EDMONTON, June 03, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS...

Ceapro Inc. Reports Financial Results for First Quarter 2024 and Provides Corporate Update

– Q1 2024 marked by significant advancement of R&D projects focused on avenanthramide Phase 1-2a clinical...

Ceapro Inc. Reports 2023 Financial Results and Operational Highlights

– 2023 marked by Ceapro’s achievement of key milestones and progress toward its next phase of growth – R&D...

Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris

TORONTO and EDMONTON, March 28, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS...

Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings

TORONTO and EDMONTON, Alberta, March 12, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX:...

Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings

TORONTO and EDMONTON, March 12, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS...

Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical Company

ISS states in its Aeterna Zentaris FOR recommendation that “on balance, the deal has strong strategic merit...

Ceapro Provides Business Update on Progress of Ongoing Development Programs, Technology and Cosmeceutical Base Business

EDMONTON, Alberta, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the...

Ceapro Inc. Announces the Mailing of Meeting Materials in Connection With the Special Meeting of Securityholders to Approve Merger With Aeterna Zentaris

EDMONTON, Alberta, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSXV: CZO) (OTCQX: CRPOF) (“Ceapro” or the...

Aeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meeting of Shareholders to Approve Merger of Equals with Ceapro

Aeterna Zentaris Board recommends shareholders vote FOR all resolutions, to create a diversified...

Aeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical Company

TORONTO and EDMONTON, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS...

Ceapro Inc. Announces Dosing of First Patients in Phase 1-2a Study Assessing Flagship Product Avenanthramides for Potential Applications in Inflammation Based Diseases

– Study being led by Dr. Jean-Claude Tardif at the Montreal Heart Institute – No adverse reactions observed...

stocker11 8年前

Have they started testing the product for Cholesterol reduction.

👍️0

stocker11 8年前

Looking to buy in soon - should I wait until for the K is filed at the end of the month?

👍️0

Michon 8年前

What make's this stock special?

👍️0

notofthisworld 8年前

This article underlines the potential of this company.

http://www.theglobeandmail.com/globe-investor/investment-ideas/why-this-canadian-biotech-firms-cheap-stock-is-a-hidden-gem/article33325243/

👍️0

notofthisworld 8年前

This won't be under 2$ for much longer.

👍️0

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Ceapro Inc (CZO)

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

CZO ニュース

Aeterna Zentaris and Ceapro Complete Merger Transaction

Aeterna Zentaris and Ceapro Complete Merger Transaction

Ceapro Inc. Reports Financial Results for First Quarter 2024 and Provides Corporate Update

Ceapro Inc. Reports 2023 Financial Results and Operational Highlights

Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris

Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings

Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings

Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical Company

Ceapro Provides Business Update on Progress of Ongoing Development Programs, Technology and Cosmeceutical Base Business

Ceapro Inc. Announces the Mailing of Meeting Materials in Connection With the Special Meeting of Securityholders to Approve Merger With Aeterna Zentaris

Aeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meeting of Shareholders to Approve Merger of Equals with Ceapro

Aeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical Company

Ceapro Inc. Announces Dosing of First Patients in Phase 1-2a Study Assessing Flagship Product Avenanthramides for Potential Applications in Inflammation Based Diseases

CZO Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

BLACK FRIDAY

Forexで最大60%オフ

1年間40％、2年間40％、*3年間60％

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Ceapro Inc (CZO) ニュース

Ceapro Inc (CZO)

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

CZO ニュース

Aeterna Zentaris and Ceapro Complete Merger Transaction

Aeterna Zentaris and Ceapro Complete Merger Transaction

Ceapro Inc. Reports Financial Results for First Quarter 2024 and Provides Corporate Update

Ceapro Inc. Reports 2023 Financial Results and Operational Highlights

Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris

Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings

Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings

Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical Company

Ceapro Provides Business Update on Progress of Ongoing Development Programs, Technology and Cosmeceutical Base Business

Ceapro Inc. Announces the Mailing of Meeting Materials in Connection With the Special Meeting of Securityholders to Approve Merger With Aeterna Zentaris

Aeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meeting of Shareholders to Approve Merger of Equals with Ceapro

Aeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical Company

Ceapro Inc. Announces Dosing of First Patients in Phase 1-2a Study Assessing Flagship Product Avenanthramides for Potential Applications in Inflammation Based Diseases

CZO Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

BLACK FRIDAY

Forexで最大60%オフ

1年間40％、2年間40％、*3年間60％